<DOC>
	<DOCNO>NCT03005249</DOCNO>
	<brief_summary>To evaluate safety efficacy neural stem cell ( NSCs ) therapy cerebral palsy .</brief_summary>
	<brief_title>Neural Stem Cells Therapy Cerebral Palsy</brief_title>
	<detailed_description>Cerebral palsy severe lifelong disability disease childhood . In China , epidemiological investigation cerebral palsy 2004 report 2.74â€° ( 6.50-9.75 million ) child suffer cerebral palsy . The cost medical expense , live allowance nursing care go RMB 20000-50000 yuan per year child cerebral palsy thus China expend RMB 120-300 billion yuan per year child cerebral palsy . With full liberalization two-child policy , increase number second baby bear woman 35 year old . Thus , incidence cerebral palsy tend increase . There currently cure cerebral palsy , result heavy burden family society . Recent clinical trial perform country outside China demonstrate stem cell therapy likely effective method treat cerebral palsy . Fifteen trial regard stem cell therapy cerebral palsy register ClinicalTrials.gov . In China , standardize registered trial regard stem cell therapy cerebral palsy , greatly restrict clinical application . In October 2016 , National Health Family Planning Commission Food Drug Administration China jointly announce premier stem cell clinical research institution , make perform standardized trial regard stem cell therapy cerebral palsy China possible .</detailed_description>
	<mesh_term>Paralysis</mesh_term>
	<mesh_term>Cerebral Palsy</mesh_term>
	<criteria>Neonates ischemic/hypoxic cerebral palsy ( mainly include neonate asphyxia premature infant ) ; Clinical manifestation spastic tetraplegia ; With moderate severe cerebral palsy , The Gross Motor Function ; Classification System ( GMFCS ) level IVV ; Age 15 year , either sex ; Provision sign informed consent one his/her parent legal guardian prior commencement study ; Systemic diseases possibly influence treatment patient 's compliance ; Potentially lifethreatening disease involve various organ system ; Brain deformity ; Abnormal behavior mood disorder ; Allergies blood product ; Suffering infectious disease ; Subjected craniocerebral operation prior screen .</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>5 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>